UCB (portfolio of Over-The-Counter medicine brands) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

UCB (portfolio of Over-The-Counter medicine brands) General Information

Description

A portfolio of Over-The-Counter drug brands in France, Benelux, Switzerland and Greece. The portfolio includes various medicine brands such as Carbolevure, Revitalose, Balsoclase and Toclase as well as different Over-The-Counter assets and patents for the distribution of drugs.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • Allée de la Recherche, 60
  • 1070 Brussels
  • Belgium
Primary Industry
Buildings and Property
Other Industries
Pharmaceuticals
Corporate Office
  • Allée de la Recherche, 60
  • 1070 Brussels
  • Belgium

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

UCB (portfolio of Over-The-Counter medicine brands) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore UCB (portfolio of Over-The-Counter medicine brands)‘s full profile, request access.

Request a free trial

UCB (portfolio of Over-The-Counter medicine brands) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore UCB (portfolio of Over-The-Counter medicine brands)‘s full profile, request access.

Request a free trial

UCB (portfolio of Over-The-Counter medicine brands) FAQs

  • Where is UCB (portfolio of Over-The-Counter medicine brands) headquartered?

    UCB (portfolio of Over-The-Counter medicine brands) is headquartered in Brussels, Belgium.

  • What industry is UCB (portfolio of Over-The-Counter medicine brands) in?

    UCB (portfolio of Over-The-Counter medicine brands)’s primary industry is Buildings and Property.

  • Is UCB (portfolio of Over-The-Counter medicine brands) a private or public company?

    UCB (portfolio of Over-The-Counter medicine brands) is a Private company.

  • What is the current valuation of UCB (portfolio of Over-The-Counter medicine brands)?

    The current valuation of UCB (portfolio of Over-The-Counter medicine brands) is .

  • What is UCB (portfolio of Over-The-Counter medicine brands)’s current revenue?

    The current revenue for UCB (portfolio of Over-The-Counter medicine brands) is .

  • Who are UCB (portfolio of Over-The-Counter medicine brands)’s investors?

    UCB has invested in UCB (portfolio of Over-The-Counter medicine brands).

  • When was UCB (portfolio of Over-The-Counter medicine brands) acquired?

    UCB (portfolio of Over-The-Counter medicine brands) was acquired on 08-Jan-2007.

  • Who acquired UCB (portfolio of Over-The-Counter medicine brands)?

    UCB (portfolio of Over-The-Counter medicine brands) was acquired by Laboratoires Pierre Fabre.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process